Masahiro Kaneko
Papers
1
Total Citations
6
H-Index
1
About
Masahiro Kaneko is a leading figure in radiation oncology, with a focused expertise in ultrahypofractionated treatments for prostate cancer. His major contribution lies in systematically comparing high-dose-rate brachytherapy (HDR-BT) with robotic and conventional stereotactic body radiotherapy (SBRT), providing critical insights into treatment planning and clinical outcomes. His landmark 2023 study, which has garnered 6 citations, directly addresses the growing use of ultrahypofractionation by evaluating dosimetric differences and potential benefits of each modality. This work helps clinicians make evidence-based decisions when selecting between these advanced techniques. Kaneko’s research is highly impactful for its practical relevance, guiding the optimization of radiation delivery to improve tumor control while minimizing toxicity. His comparative analyses are essential reading for radiation oncologists and medical physicists seeking to refine prostate cancer management. Through his rigorous methodology and clear clinical focus, Kaneko continues to shape the landscape of modern radiotherapy, offering valuable benchmarks for future studies and clinical protocols.
Research Focus
Key Achievements
Top Papers
- 1